GRTX
Galera Therapeutics, Inc.
Set alert
17.15 USD 0.00 0.00%
16.00 Day range 17.15
0.01 52-week range 16.70
- YTD
- +77,854.55%
- 1 year
- +59,037.93%
- Open
- 16.00
- Prev close
- 17.15
- Mkt cap
- 3.56B
- Vol
- 420
- Avg vol
- 84.88K
- EPS
- 0.64
- P/E
- 0.06
- Div yield
- 0.00%
More statistics
- Low
- 16.00
- High
- 17.15
- Beta
- 2.60
- Inst. own
- 0.00%
- Dividend
- 0.00
Ownership
Held by insiders 0.00%
Held by institutions 0.00%
Float held by institutions 0.00%
Institutions 0
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Ascentis Independent Advisors | 0.00% | 93 | 1.51K | Mar 30, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Master Investment Portfolio-Diversified Equity Master Portfolio | 0.00% | 7 | 113 | Mar 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHANG NANCY T | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Apr 6, 2026 | 8,825,540 |
| EMERALD BIOVENTURES LLC | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | May 14, 2026 | 0 |
| FRIEDMAN MICHAEL R | Director | Conversion of Exercise of derivative security | Apr 6, 2026 | 0 |
| SORENSEN J. MEL | Chief Executive Officer | Sale | Nov 19, 2025 | 195,029 |
| SORENSEN MELINDA | Chief Executive Officer | Sale | Nov 19, 2025 | 195,029 |